Zhao Z et al. found that sodium butyrate attenuates COPD inflammation induced by cigarette smoke by activating G Protein-Coupled Receptor 43 (GPR43), thereby inhibiting NF-κB/MAPK signaling pathways [21]. This evidence concerns the gene FFAR2 and chronic obstructive pulmonary disease.